Effective Antibiotic Therapy of Complicated Urinary Tract Infections
DOI:
https://doi.org/10.22141/2307-1257.0.4.14.2015.74892Abstract
The article presents data from a study on the clinical and bacteriological efficacy and safety of Brakson (tobramycin) in the treatment of complicated urinary tract infections. The results demonstrated the feasibility of the administration of this antibacterial drug in patients with complicated urinary tract infections. According to laboratory tests of antimicrobial activity of Brakson, its efficiency is 87 %. Also a high level of safety of Brakson (93.3 %) has been shown. This allows us to recommend the use of Brakson in complicated urinary tract infections as monotherapy.Downloads
References
Grabe M., Bjerklund-Johansen T., Botto H., Naber K., Bishop M. Guidelines on urological infections. 2010: European Association of Urology.
Brown P.D. Antibiotic selection for urinary tract infection: new microbiologic consideration // Curr. Infect. Dis. Rep. 1999; 1: 384-387.
Nicolle L.E. Urinary tract infection: traditional pharmacologic therapies // Am. J. Med. 2002; 113 (Suppl. 1A): 35S-44S.
Grude N., Tveten Y., Jenkins A., Kristiansen B.E. Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment // Scand. J. Prim. Health Care 2005; 23(2): 115-119.
Foxmann B., Barlow R., D’Arcy H. et al. Urinary tract infection: Self-reported incidence and associated costs // Ann. Epid. 2000; 10: 509-515.
Wagenlehner F.M., Naber K.G. Treatment of bacterial urinary tract infections: presence and future // Eur. Urol. 2006; 49(2): 235-244.
Williams D.H., Schaeffer A.J. Current concepts in urinary tract infections // Minerva Urol. Nephrol. 2004; 56(1): 15-31.
Tolkoff-Rubin N.E., Cotran R.S., Rubin R.H. Urinary tract infections, pyelonephritis, and reflux nephropathy // Brenner B.M., ed. The Kidney, sixth ed. W.B. Saunders, Philadelphia et al., 2000; 1449-1508.
Ramakrishnan K., Scheid D.C. Diagnosis and management of acute pyelonephritis in adults // Am. J. Fam. Phys. 2005; 71(5): 933-941.
Lynch D.M. Cranberry for prevention of urinary tract infection // Am. Fam. Phys. 2004; 70(11): 2175-2177.
Dodd M.C., Stillman W.В. The in vitro bacteriostatic action of some simple furan derivatives // J. Pharmacol. Exp. Ther. 1944; 82: 11-18.
Mesa Española de Normalización de la Sensibilidad y Resistencia a los Antimicrobianos. Recomendaciones del grupo MENSURA para la selección de antimicrobianos en el estudio de la sensibilidad y criterios para la interpretación del antibiograma. MENSURA, Madrid, Spain. 2005.
Рафальский В.В., Ходневич Л.В. Влияние резистентности возбудителей инфекций мочевыводящих путей на исходы антибактериальной терапии // Урология 2008; 4: c. 3-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 O.D. Nikitin
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN 2307-1257
ISSN 2307-1265
